Ondrey Aaron 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Ondrey Aaron
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-04-01+69,337→ 69,337 totalExercise: $26.72Exp: 2034-04-01→ Common Stock (69,337 underlying) - Award
Common Stock
2024-04-01+46,781→ 46,781 total
Footnotes (2)
- [F1]Holdings are Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. One-third (1/3) of such RSUs will become fully vested on April 1, 2025, with the remaining shares vesting in equal quarterly installments over the following two years.
- [F2]This option represents a right to purchase a total of 69,337 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on April 1, 2025, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer.